# Effect of BMS-914392 on Pharmacokinetics of Metoprolol

> **NCT01211821** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 18 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** metoprolol
- **DRUG:** BMS-914392

## Key facts

- **NCT ID:** NCT01211821
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2011-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01211821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01211821, "Effect of BMS-914392 on Pharmacokinetics of Metoprolol". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT01211821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*